Get started

Subscribe

Intec Pharma LTD stock analysisCompany: Intec Pharma LTD Quote:NASDAQ: NTEC Buy Target : $6.90 (original hold) $7.25 Second entry Sell Target: $30 EOY , Description: Intec Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. It's Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism. Short Interest: Short Percent of Float ?% Short % Increase / Decrease 21 % Tapes last week: 1/5 Very bearish no major buying and large sell blocks during the week Please follow us on our Facebook and Twitter to get the analysis on your social media. Subscribe to our newsletter to get our analysis directly to your mail Facebook - @SFYBUofficial Twitter - @SFYBUofficial
NLong
by SFYBUofficial